Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease

References

• MakitaHNasuharaYNagaiKHokkaido COPD Cohort Study GroupCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
   PubMed Web of Science ®Google Scholar
• PatelBMakeBCoxsonHOAirway and parenchymal disease in chronic obstructive pulmonary disease are distinct phenotypesProc Am Thorac Soc200636533
   Google Scholar
• HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• YaoHRahmanICurrent concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary diseaseToxicol Appl Pharmacol20112542728521296096
   PubMed Web of Science ®Google Scholar
• ToyoshimaMChidaKSudaTSatoMIs autoimmunity really related to the pathogenesis of COPD?Am J Respir Crit Care Med2011184101212121322086993
   PubMed Web of Science ®Google Scholar
• BarbuCIordacheMManMGInflammation in COPD: pathogenesis, local and systemic effectsRom J Morphol Embryol2011521212721424028
   PubMed Web of Science ®Google Scholar
• CornwellWDKimVSongCRogersTJPathogenesis of inflammation and repair in advanced COPDSemin Respir Crit Care Med201031325726620496295
   PubMed Web of Science ®Google Scholar
• FukeSBetsuyakuTNasuharaYMorikawaTKatohHNishimuraMChemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol200431440541215220136
   PubMed Web of Science ®Google Scholar
• LamsBESousaARReesPJLeeTHSubepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary diseaseEur Respir J200015351251610759445
   PubMed Web of Science ®Google Scholar
• O’ShaughnessyTCAnsariTWBarnesNCJefferyPKInflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1Am J Respir Crit Care Med199715538528579117016
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoATuratoGCD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981573 Pt 18228269517597
   PubMed Web of Science ®Google Scholar
• BaraldoSTuratoGBadinCNeutrophilic infiltration within the airway smooth muscle in patients with COPDThorax200459430831215047950
   PubMed Web of Science ®Google Scholar
• MiottoDRuggieriMPBoschettoPInterleukin-13 and -4 expression in the central airways of smokers with chronic bronchitisEur Respir J200322460260814582911
   PubMed Web of Science ®Google Scholar
• SaettaMTuratoGMaestrelliPMappCEFabbriLMCellular and structural bases of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116361304130911371392
   PubMed Web of Science ®Google Scholar
• DaheshiaMTherapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD)Curr Med Res Opin200521458759415899108
   PubMed Web of Science ®Google Scholar
• MacneeWRahmanIOxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 2S58S6510556172
   PubMed Web of Science ®Google Scholar
• MocchegianiEGiacconiRCostarelliLMetalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implicationsCurr Opin Pulm Med201117Suppl 1S11S1922209925
   PubMed Web of Science ®Google Scholar
• ChurgAZhouSWrightJLSeries “matrix metalloproteinases in lung health and disease”: matrix metalloproteinases in COPDEur Respir J201239119720921920892
   PubMed Web of Science ®Google Scholar
• MalemudCJMatrix metalloproteinases (MMPs) in health and disease: an overviewFront Biosci2006111696170116368548
   PubMed Web of Science ®Google Scholar
• HautamakiRDKobayashiDKSeniorRMShapiroSDRequirement for macrophage elastase for cigarette smoke-induced emphysema in miceScience19972775334200220049302297
   PubMed Web of Science ®Google Scholar
• HassettDJBorchersMTPanosRJChronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectivesJ Microbiol201452321122624585052
   PubMed Web of Science ®Google Scholar
• WozniakAGoreckiDSzpindaMMila-KierzenkowskaCWozniakBOxidant-antioxidant balance in the blood of patients with chronic obstructive pulmonary disease after smoking cessationOxid Med Cell Longev2013201389707524089631
   PubMed Web of Science ®Google Scholar
• CristovaoCCristovaoLNogueiraFBichoMEvaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary diseaseRev Port Pneumol2013192707523199890
   PubMed Web of Science ®Google Scholar
• AhmadAShameemMHusainQAltered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis20131781104110923827037
   PubMed Web of Science ®Google Scholar
• NicksMEO’BrienMMBowlerRPPlasma antioxidants are associated with impaired lung function and COPD exacerbations in smokersCOPD20118426426921627570
   PubMedGoogle Scholar
• IvesSJHarrisRAWitmanMAVascular dysfunction and chronic obstructive pulmonary disease: the role of redox balanceHypertension201463345946724324045
   PubMed Web of Science ®Google Scholar
• AaronSDAngelJBLunauMGranulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001163234935511179105
   PubMed Web of Science ®Google Scholar
• GompertzSBayleyDLHillSLStockleyRARelationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPDThorax2001561364111120902
   PubMed Web of Science ®Google Scholar
• PinamontiSLeisMBarbieriADetection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary diseaseFree Radic Biol Med19982577717799823542
   PubMed Web of Science ®Google Scholar
• BindoliAFukutoJMFormanHJThiol chemistry in peroxidase catalysis and redox signalingAntioxid Redox Signal20081091549156418479206
   PubMed Web of Science ®Google Scholar
• ChurchDFPryorWAFree-radical chemistry of cigarette smoke and its toxicological implicationsEnviron Health Perspect1985641111263007083
   PubMed Web of Science ®Google Scholar
• RahmanIvan SchadewijkAACrowtherAJ4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166449049512186826
   PubMed Web of Science ®Google Scholar
• CantinAMNorthSLHubbardRCCrystalRGNormal alveolar epithelial lining fluid contains high levels of glutathioneJ Appl Physiol (1985)19876311521573040659
   PubMed Web of Science ®Google Scholar
• YaoHArunachalamGHwangJWExtracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECMProc Natl Acad Sci U S A201010735155711557620713693
   PubMed Web of Science ®Google Scholar
• ChristmanJWSadikotRTBlackwellTSThe role of nuclear factor-kappa B in pulmonary diseasesChest200011751482148710807839
   PubMed Web of Science ®Google Scholar
• PantanoCReynaertNLvan der VlietAJanssen-HeiningerYMRedox-sensitive kinases of the nuclear factor-kappaB signaling pathwayAntioxid Redox Signal200689–101791180616987032
   PubMed Web of Science ®Google Scholar
• SenguptaNSetoERegulation of histone deacetylase activitiesJ Cell Biochem2004931576715352162
   PubMed Web of Science ®Google Scholar
• ItoKItoMElliottWMDecreased histone deacetylase activity in chronic obstructive pulmonary diseaseN Engl J Med2005352191967197615888697
   PubMed Web of Science ®Google Scholar
• YangSRChidaASBauterMRCigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophagesAm J Physiol Lung Cell Mol Physiol20062911L46L5716473865
   PubMed Web of Science ®Google Scholar
• PotenteMDimmelerSEmerging roles of SIRT1 in vascular endothelial homeostasisCell Cycle20087142117212218641460
   PubMed Web of Science ®Google Scholar
• RajendrasozhanSYangSRKinnulaVLRahmanISIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177886187018174544
   PubMed Web of Science ®Google Scholar
• KenslerTWWakabayashiNBiswalSCell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathwayAnnu Rev Pharmacol Toxicol2007478911616968214
   PubMed Web of Science ®Google Scholar
• GovenDBouttenALecon-MalasVAltered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysemaThorax2008631091692418559366
   PubMed Web of Science ®Google Scholar
• MalhotraDThimmulappaRNavas-AcienADecline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1Am J Respir Crit Care Med2008178659260418556627
   PubMed Web of Science ®Google Scholar
• SuzukiMBetsuyakuTItoYDown-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol200839667368218566336
   PubMed Web of Science ®Google Scholar
• AdenugaDCaitoSYaoHNrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reductionBiochem Biophys Res Commun20104033–445245621094147
   PubMed Web of Science ®Google Scholar
• MercadoNThimmulappaRThomasCMDecreased histone deacetylase 2 impairs Nrf2 activation by oxidative stressBiochem Biophys Res Commun2011406229229821320471
   PubMed Web of Science ®Google Scholar
• BrittonJRPavordIDRichardsKADietary antioxidant vitamin intake and lung function in the general populationAm J Respir Crit Care Med19951515138313877735589
   PubMed Web of Science ®Google Scholar
• GrievinkLSmitHAOckeMCvan ‘t VeerPKromhoutDDietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN studyThorax19985331661719659349
   PubMed Web of Science ®Google Scholar
• RautalahtiMVirtamoJHaukkaJThe effect of alpha-tocopherol and beta-carotene supplementation on COPD symptomsAm J Respir Crit Care Med19971565144714529372659
   PubMed Web of Science ®Google Scholar
• SargeantLAJaeckelAWarehamNJInteraction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk. European Prospective Investigation into Cancer and NutritionEur Respir J200016339740311028650
   PubMed Web of Science ®Google Scholar
• ArtsICHollmanPCPolyphenols and disease risk in epidemiologic studiesAm J Clin Nutr200581Suppl 1317S325S15640497
   PubMed Web of Science ®Google Scholar
• TabakCArtsICSmitHAHeederikDKromhoutDChronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN StudyAm J Respir Crit Care Med20011641616411435239
   PubMed Web of Science ®Google Scholar
• SantusPSolaACarlucciPLipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171883884315579728
   PubMed Web of Science ®Google Scholar
• WaldaICTabakCSmitHADiet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countriesEur J Clin Nutr200256763864312080403
   PubMed Web of Science ®Google Scholar
• KodeARajendrasozhanSCaitoSYangSRMegsonILRahmanIResveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cellsAm J Physiol Lung Cell Mol Physiol20082943L478L48818162601
   PubMed Web of Science ®Google Scholar
• BiswasSKMcClureDJimenezLAMegsonILRahmanICurcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activityAntioxid Redox Signal200571–2324115650394
   PubMed Web of Science ®Google Scholar
• CulpittSVRogersDFFenwickPSInhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPDThorax2003581194294614586044
   PubMed Web of Science ®Google Scholar
• MannaSKMukhopadhyayAAggarwalBBResveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidationJ Immunol2000164126509651910843709
   PubMed Web of Science ®Google Scholar
• ShishodiaSPotdarPGairolaCGAggarwalBBCurcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1Carcinogenesis20032471269127912807725
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE study): a randomised placebo-controlled studyLancet200837196292013201818555912
   PubMed Web of Science ®Google Scholar
• MorettiMBottrighiPDallariRThe effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE studyDrugs Exp Clin Res200430414315215553660
   PubMedGoogle Scholar
• MorettiMMarchioniCFAn overview of erdosteine antioxidant activity in experimental researchPharmacol Res200755424925417267240
   PubMed Web of Science ®Google Scholar
• Dal NegroRWViscontiMMichelettoCTognellaSChanges in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPDPulm Pharmacol Ther200821230430817889580
   PubMed Web of Science ®Google Scholar
• RheeCKKangCMYouMBEffect of fudosteine on mucin productionEur Respir J20083251195120218579549
   PubMed Web of Science ®Google Scholar
• RahmanIAntioxidant therapeutic advances in COPDTher Adv Respir Dis20082635137419124382
   PubMedGoogle Scholar
• RahmanIPharmacological antioxidant strategies as therapeutic interventions for COPDBiochim Biophys Acta20121822571472822101076
   PubMed Web of Science ®Google Scholar
• DavisSSScobieSInglisAThe effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucusBiorheology1975123–42252321125
   PubMed Web of Science ®Google Scholar
• SadowskaAMN-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary diseaseTher Adv Respir Dis20126312713522361928
   PubMed Web of Science ®Google Scholar
• SheffnerALThe reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteineAnn N Y Acad Sci196310629831013977050
   PubMed Web of Science ®Google Scholar
• MataMRuizACerdaMOral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in ratsEur Respir J200322690090514680076
   PubMed Web of Science ®Google Scholar
• SadowskaAMManuelYKBDe BackerWAAntioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a reviewPulm Pharmacol Ther200720192216458553
   PubMed Web of Science ®Google Scholar
• MoldeusPCotgreaveIABerggrenMLung protection by a thiol-containing antioxidant: N-acetylcysteineRespiration198650Suppl 131423809741
   PubMed Web of Science ®Google Scholar
• BridgemanMMMarsdenMMacNeeWFlenleyDCRyleAPCysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteineThorax199146139421871695
   PubMed Web of Science ®Google Scholar
• KasielskiMNowakDLong-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary diseaseRespir Med200195644845611421501
   PubMed Web of Science ®Google Scholar
• BridgesRBProtective action of thiols on neutrophil functionEur J Respir Dis Suppl198513940483862610
   PubMedGoogle Scholar
• DrostELannanSBridgemanMMLack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophagesEur Respir J1991467237291889500
   PubMed Web of Science ®Google Scholar
• JefferyPKRogersDFAyersMMEffect of oral acetylcysteine on tobacco smoke-induced secretory cell hyperplasiaEur J Respir Dis Suppl19851391171223862604
   PubMedGoogle Scholar
• EklundAErikssonOHakanssonLOral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variablesEur Respir J1988198328382852604
   PubMed Web of Science ®Google Scholar
• van OverveldFJVermeirePADe BackerWAInduced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factorsInflamm Res200049181310778915
   PubMed Web of Science ®Google Scholar
• BorgstromLKagedalBDose dependent pharmacokinetics of N-acetylcysteine after oral dosing to manBiopharm Drug Dispos19901121311362328298
   PubMed Web of Science ®Google Scholar
• CotgreaveIAMoldeusPLung protection by thiol-containing antioxidantsBull Eur Physiopathol Respir19872342752773318962
   PubMedGoogle Scholar
• BridgemanMMMarsdenMSelbyCMorrisonDMacNeeWEffect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissueThorax19944976706758066561
   PubMed Web of Science ®Google Scholar
• De BenedettoFAcetoADraganiBLong-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPDPulm Pharmacol Ther2005181414715607126
   PubMed Web of Science ®Google Scholar
• LundbackBLMAnderssonSPossible effect of acetylcysteine on lung functionEur Respir J19925Suppl 15895
   Google Scholar
• DecramerMRutten-van MolkenMDekhuijzenPNEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet200536594701552156015866309
   PubMed Web of Science ®Google Scholar
• PoolePBlackPNCatesCJMucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20128CD00128722895919
   PubMed Web of Science ®Google Scholar
• RubioMLSanchez-CifuentesMVOrtegaMN-acetylcysteine prevents cigarette smoke induced small airways alterations in ratsEur Respir J200015350551110759444
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE studyChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• GoldmanMDSaadehCRossDClinical applications of forced oscillation to assess peripheral airway functionRespir Physiol Neurobiol20051481–217919415990365
   PubMed Web of Science ®Google Scholar
• GrimbyGTakishimaTGrahamWMacklemPMeadJFrequency dependence of flow resistance in patients with obstructive lung diseaseJ Clin Invest1968476145514655653219
   PubMed Web of Science ®Google Scholar
• BrochardLPelleGde PalmasJDensity and frequency dependence of resistance in early airway obstructionAm Rev Respir Dis198713535795843826883
   PubMed Web of Science ®Google Scholar
• FariaACCostaAALopesAJJansenJMMeloPLForced oscillation technique in the detection of smoking-induced respiratory alterations: diagnostic accuracy and comparison with spirometryClinics (Sao Paulo)201065121295130421340218
   PubMed Web of Science ®Google Scholar
• StavDRazMEffect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled studyChest2009136238138619447919
   PubMed Web of Science ®Google Scholar
• HanaokaMDromaYChenYCarbocisteine protects against emphysema induced by cigarette smoke extract in ratsChest201113951101110820847042
   PubMed Web of Science ®Google Scholar
• RubioMLMartin-MosqueroMCOrtegaMPeces-BarbaGGonzalez-MangadoNOral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in ratsChest200412541500150615078764
   PubMed Web of Science ®Google Scholar
• CaiSChenPZhangCChenJBWuJOral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in ratsRespirology200914335435919341424
   PubMed Web of Science ®Google Scholar
• Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled studyEur J Respir Dis Suppl1980111931087011836
   PubMedGoogle Scholar
• [No authors listed]Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research CommitteeThorax198540118328352866607
   PubMed Web of Science ®Google Scholar
• BomanGBackerULarssonSMelanderBWahlanderLOral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary DiseasesEur J Respir Dis19836464054156350033
   PubMedGoogle Scholar
• GrassiCMorandiniGCA controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitisEur J Clin Pharmacol197695–6393396786665
   PubMed Web of Science ®Google Scholar
• HansenNCSkriverABrorsen-RiisLOrally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitisRespir Med19948875315357972979
   PubMed Web of Science ®Google Scholar
• PelaRCalcagniAMSubiacoSIsidoriPTubaldiASanguinettiCMN-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPDRespiration199966649550010575333
   PubMed Web of Science ®Google Scholar
• RasmussenJBGlennowCReduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitisEur Respir J1988143513553294038
   PubMed Web of Science ®Google Scholar
• SchermerTChavannesNDekhuijzenRFluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitisRespir Med2009103454255119138505
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• GerritsCMHeringsRMLeufkensHGLammersJWN-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary diseaseEur Respir J200321579579812765423
   PubMed Web of Science ®Google Scholar
• GrandjeanEMBerthetPRuffmannRLeuenbergerPEfficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trialsClin Ther200022220922110743980
   PubMed Web of Science ®Google Scholar
• SteyCSteurerJBachmannSMediciTCTramerMRThe effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic reviewEur Respir J200016225326210968500
   PubMed Web of Science ®Google Scholar
• NiedermanMSRaffertyTDSasakiCTMerrillWWMatthayRAReynoldsHYComparison of bacterial adherence to ciliated and squamous epithelial cells obtained from the human respiratory tractAm Rev Respir Dis1983127185906401417
   PubMed Web of Science ®Google Scholar
• SuerESayracSSarinayEVariation in the attachment of Streptococcus pneumoniae to human pharyngeal epithelial cells after treatment with S-carboxymethylcysteineJ Infect Chemother200814433333618709541
   PubMedGoogle Scholar
• Radomska-LesniewskaDMSadowskaAMVan OverveldFJDemkowUZielinskiJDe BackerWAInfluence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cellsJ Physiol Pharmacol200657Suppl 432533417072061
   PubMed Web of Science ®Google Scholar
• SinojiaRShaikhMKodguleRPriming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200 mg/day NAC in moderate to severe COPD patients: a pilot studyRespir Physiol Neurobiol2014191525924211316
   PubMed Web of Science ®Google Scholar
• LindenMWieslanderEEklundALarssonKBrattsandREffects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokersEur Respir J1988176456502846345
   PubMed Web of Science ®Google Scholar
• RiiseGCQvarfordtILarssonSEliassonVAnderssonBAInhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitroRespiration200067555255811070462
   PubMed Web of Science ®Google Scholar
• WuWPatelKBBoothJLZhangWMetcalfJPCigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lungAm J Physiol Lung Cell Mol Physiol20113006L821L83021335520
   PubMed Web of Science ®Google Scholar
• TseHNRaiteriLWongKYNgLYYeeKSTsengCZBenefits of high dose N-acetylcysteine to exacerbation-prone COPD patientsChest5152014 [Epub ahead of print.]
   Web of Science ®Google Scholar
• ZhouYWangXZengXPositive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 yearRespirology200611560361016916334
   PubMed Web of Science ®Google Scholar
• McGavinCRMacfarlaneJTPrescottRJElmesPFergusonANarimanSStableforthDOral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstructionThorax1985408328352866607
   PubMed Web of Science ®Google Scholar
• BaboliniHCharpinJGermoutyJMulticenter study group. Long term oral acetylcysteine in chronic bronchitis. A double-blind controlled studyEur J Respir Dis Suppl198061Suppl 11193108
   Google Scholar